StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) stock

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30217% above fair value
$132.81−4.97 (-3.61%)

Close on Nov 19, 2026Market cap $327.67BP/E 106.2Yield 2.47%

Merck operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

No operating income figures for Merck

Merck has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Merck figures

See a number that looks wrong?